SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q3 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $209,000 | -85.0% | 1,191 | -95.5% | 0.02% | -67.6% |
Q1 2018 | $1,391,000 | -0.4% | 26,569 | +1.8% | 0.07% | 0.0% |
Q4 2017 | $1,396,000 | +1.9% | 26,087 | +3.6% | 0.07% | -5.3% |
Q3 2017 | $1,370,000 | +0.8% | 25,171 | -4.1% | 0.08% | -2.6% |
Q2 2017 | $1,359,000 | -17.1% | 26,258 | +0.7% | 0.08% | -18.9% |
Q1 2017 | $1,639,000 | +4.9% | 26,081 | -11.9% | 0.10% | -3.1% |
Q4 2016 | $1,562,000 | -21.8% | 29,599 | -19.9% | 0.10% | -23.4% |
Q3 2016 | $1,997,000 | +29.8% | 36,974 | -2.9% | 0.13% | +21.9% |
Q2 2016 | $1,539,000 | +20.4% | 38,087 | +4.6% | 0.10% | +12.9% |
Q1 2016 | $1,278,000 | -24.5% | 36,429 | -3.4% | 0.09% | -27.3% |
Q4 2015 | $1,692,000 | -63.4% | 37,698 | -80.1% | 0.13% | -72.8% |
Q3 2015 | $4,624,000 | +287.6% | 189,816 | +669.9% | 0.47% | +286.1% |
Q2 2015 | $1,193,000 | +92.4% | 24,656 | +40.6% | 0.12% | +79.4% |
Q1 2015 | $620,000 | +117.5% | 17,532 | +97.5% | 0.07% | +83.8% |
Q4 2014 | $285,000 | – | 8,875 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |